Attributable mortality of ventilator-associated pneumonia

Current Opinion in Critical Care

Volumn 17, Issue 5, 2011, Pages 464-471

  Timsit, Jean François ^a,b   Zahar, Jean Ralph ^a,c   Chevret, Sylvie ^d  

^a INSTITUT ALBERT BONNIOT   (France)

^b HÔPITAL MICHALLON   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSERM   (France)

Author keywords

attributable mortality; multistate models; survival models competing risks; ventilatorassociated pneumonia

Indexed keywords

CAUSAL MODELING; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; INFECTION; MORTALITY; MULTIPLE ORGAN FAILURE; REVIEW; RISK ASSESSMENT; SURVIVAL; VENTILATOR ASSOCIATED PNEUMONIA;

HOSPITAL MORTALITY; HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED; SURVIVAL ANALYSIS;

EID: 80052718414     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32834a5ae9     Document Type: Review

References (88)

1. Klompas M, Platt R. Ventilator-associated pneumonia: the wrong quality measure for benchmarking. Ann Intern Med 2007; 147:803-805. (Pubitemid 351664444)
2. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33:2184-2193.
3. Koulenti D, Lisboa T, Brun-Buisson C, et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009; 37:2360-2368.
4. Timsit JF, Misset B, Azoulay E, et al. Usefulness of airway visualization in the diagnosis of nosocomial pneumonia in ventilated patients. Chest 1996; 110:172-179. (Pubitemid 26249320)
5. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903. (Pubitemid 34774654)
6. Bonten MJ, Bergmans DC, Stobberingh EE, et al. Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med 1997; 156:1820-1824. (Pubitemid 28011788)
7. Timsit JF, Cheval C, Gachot B, et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med 2001; 27:640-647. (Pubitemid 32304566)
8. Conway Morris AC, Kefala K, Simpson AJ, et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 2009; 64:516-522.
9. Prats E, Dorca J, Pujol M, et al. Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J 2002; 19: 944-951. (Pubitemid 34567911)
10. Souweine B, Veber B, Bedos JP, et al. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med 1998; 26:236-244. (Pubitemid 28082683)
11. Timsit JF. Bronchoalveolar lavage for VAP diagnosis: patients must be sampled before any change of antimicrobial therapy. Intensive Care Med 2007; 33:1690-1693.
12. L'Heriteau F, Alberti C, Cohen Y, et al. Nosocomial infection and multidrugresistant bacteria surveillance in intensive care units: a survey in France. Infect Control Hosp Epidemiol 2005; 26:13-20. (Pubitemid 40110964)
13. Canadian CriticalCare Trials Group.Arandomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355:2619-2630.
14. Melsen WG, Rovers MM, Bonten MJ. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 2009; 37:2709-2718.
15. Lisboa T, Diaz E, Sa-Borges M, et al. The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest 2008; 134:1208-1216.
16. Mirsaeidi M, Peyrani P, Ramirez JA. Predicting mortality in patients with ventilator-associated pneumonia: the APACHE II score versus the new IBMP-10 score. Clin Infect Dis 2009; 49:72-77.
17. Hedrick TL, Smith RL, McElearney ST, et al. Differences in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 2008; 64:714-720. (Pubitemid 351366897)
18. Nguile-Makao M, Zahar JR, Francais A, et al. Attributable mortality of ventilatorassociated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multistate models. Intensive Care Med 2010; 36:781-789.
19. Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, et al. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 1994; 22:55-60.
20. Kim PW, Perl TM, Keelaghan EF, et al. Risk of mortality with a bloodstream infection is higher in the less severely ill at admission. Am J Respir Crit Care Med 2005; 171:616-620. (Pubitemid 40365417)
21. Moine P, Timsit JF, De Lassence A, et al. Mortality associated with late-onset pneumonia in the intensive care unit: results of a multicenter cohort study. Intensive Care Med 2002; 28:154-163. (Pubitemid 34293827)
22. Kollef MH, Shapiro SD, Fraser VJ, et al. Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial. Ann Intern Med 1995; 123:168-174.
23. Ibrahim EH, Ward S, Sherman G, Kollef MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000; 117:1434-1442. (Pubitemid 30321602)
24. Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilatorassociated pneumonia in determining patient mortality. Chest 1995; 108: 1655-1662.
25. Valles J, Pobo A, Garcia-Esquirol O, et al. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. Intensive Care Med 2007; 33:1363-1368. (Pubitemid 47101716)
26. Agbaht K, Diaz E, Munoz E, et al. Bacteremia in patients with ventilatorassociated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med 2007; 35:2064-2070. (Pubitemid 47326442)
27. Lambert ML, Suetens C, Savey A, et al. Clinical outcomes of health-careassociated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011; 11:30-38.
28. Luna CM, Aruj P, Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006; 27:158-164. (Pubitemid 43092680)
29. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268. (Pubitemid 34754172)
30. Kollef MH, ShermanG, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474. (Pubitemid 29083057)
31. Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care 2008; 23:91-100. (Pubitemid 351400347)
32. Clec'h C, Timsit JF, De Lassence A, et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity. Intensive Care Med 2004; 30:1327-1333. (Pubitemid 38951714)
33. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 2007; 35:1888-1895. (Pubitemid 47220363)
34. Combes A, Luyt CE, Fagon JY, et al. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007; 35:146-154. (Pubitemid 46035690)
35. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001; 29:2303-2309. (Pubitemid 34038163)
36. Zahar JR, Clec'h C, Tafflet M, et al. Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? Clin Infect Dis 2005; 41:1224-1231. (Pubitemid 41532663)
37. Combes A, Luyt CE, Fagon JY, et al. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 2004; 170:786-792. (Pubitemid 39298995)
38. Kaminski C, Timsit JF, Dubois Y, et al. Impact of ureido/ carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit Care 2011; 15:R112.
39. Zahar JR, Timsit JF, Garrouste-Orgeas M, et al. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med 2011; 39:1886-1895.
40. Froon AH, Bonten MJ, Gaillard CA, et al. Prediction of clinical severity and outcome of ventilator-associated pneumonia. Comparison of simplified acute physiology score with systemic inflammatory mediators. Am J Respir Crit Care Med 1998; 158:1026-1031. (Pubitemid 28488996)
41. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-528. (Pubitemid 20292709)
42. Rello J, Rue M, Jubert P, et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997; 25:1862-1867. (Pubitemid 27483968)
43. Timsit JF, Chevret S, Valcke J, et al. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med 1996; 154:116-123. (Pubitemid 26255776)
44. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV Jr. Ventilatorassociated pneumonia due to Pseudomonas aeruginosa. Chest 1996; 109:1019-1029. (Pubitemid 26113647)
45. Gefeller O. Definitions of attributable risk: revisited. Public Health Rev 1995; 23:343-355.
46. Burgmann H, Hiesmayr JM, Savey A, et al. Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients. Intensive Care Med 2010; 36:1597-1601.
47. Ibrahim EH, Tracy L, Hill C, et al. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001; 120:555-561. (Pubitemid 32881275)
48. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medicalsurgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003; 31:291-295. (Pubitemid 36960666)
49. Garrouste Orgeas M, Timsit JF, Soufir L, et al. Impact of adverse events on outcomes in intensive care unit patients. Crit Care Med 2008; 36:2041-2047.
50. Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133:792-796. (Pubitemid 16116505)
51. Fagon JY, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275:866-869. (Pubitemid 26087224)
52. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-644.
53. Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci 2010; 25:1-21.
54. Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical and economic outcomes attributable to healthcare-associated sepsis and pneumonia. Arch Intern Med 2010; 170:347-353.
55. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159 (4 Pt 1):1249-1256. (Pubitemid 29202563)
56. Hugonnet S, Eggimann P, Borst F, et al. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 2004; 25:1090-1096. (Pubitemid 39664738)
57. Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA 2000; 284:2361-2367.
58. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154:91-97. (Pubitemid 26255772)
59. Leu HS, Kaiser DL, Mori M, et al. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 1989; 129:1258-1267. (Pubitemid 19148466)
60. Leone M, Bourgoin A, Giuly E, et al. Influence on outcome of ventilatorassociated pneumonia in multiple trauma patients with head trauma treated with selected digestive decontamination. Crit Care Med 2002; 30:1741-1746. (Pubitemid 34879584)
61. Leroy O, Guilley J, Georges H, et al. Effect of hospital-acquired ventilatorassociated pneumonia on mortality of severe community-acquired pneumonia. J Crit Care 1999; 14:12-19. (Pubitemid 29129403)
62. Bregeon F, Ciais V, Carret V, et al. Is ventilator-associated pneumonia an independent risk factor for death? Anesthesiology 2001; 94:554-560. (Pubitemid 32249611)
63. Foglia E, MeierMD, Elward A. Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients. Clin Microbiol Rev 2007; 20:409-425. (Pubitemid 47175011)
64. Uno H, Takezawa J, Yatsuya H, et al. Impact of intensive-care-unit (ICU)- acquired ventilator-associated pneumonia (VAP) on hospital mortality: a matched-paired case-control study. Nagoya J Med Sci 2007; 69:29-36.
65. Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008; 61:1216-1221.
66. Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M. Efficient risk set sampling when a time-dependent exposure is present: matching for time to exposure versus exposure density sampling. Methods Inf Med 2009; 48:438-443.
67. Colpan A, Akinci E, Erbay A, et al. Evaluation of risk factors for mortality in intensive care units: a prospective study from a referral hospital in Turkey. Am J Infect Control 2005; 33:42-47. (Pubitemid 40430796)
68. Prowle JR, Echeverri JE, Ligabo EV, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care 2011; 15:R100.
69. Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5:368-375. (Pubitemid 34130340)
70. Resche-Rigon M, Azoulay E, Chevret S. Evaluating mortality in intensive care units: contribution of competing risks analyses. Crit Care 2006; 10:R5.
71. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Statist Assoc 1999; 94:496-509.
72. Wolkewitz M, Vonberg RP, Grundmann H, et al. Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008; 12:R44.
73. Darmon M, Timsit JF, Francais A, et al. Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant 2010; 25:2510-2515.
74. Andersen PK, Abildstrom SZ, Rosthoj S. Competing risks as a multistate model. Stat Methods Med Res 2002; 11:203-215.
75. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multistate models. Stat Med 2007; 26:2389-2430. (Pubitemid 46730255)
76. Beyersmann J, Gastmeier P, Grundmann H, et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006; 27:493-499. (Pubitemid 43835532)
77. Schulgen G, Kropec A, Kappstein I, et al. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol 2000; 53:409-417. (Pubitemid 30216480)
78. Escolano S, Golmard JL, Korinek AM, Mallet A. A multistate model for evolution of intensive care unit patients: prediction of nosocomial infections and deaths. Stat Med 2000; 19:3465-3482. (Pubitemid 32056697)
79. Schumacher M, Wangler M, Wolkewitz M, Beyersmann J. Attributable mortality due to nosocomial infections. A simple and useful application of multistate models. Methods Inf Med 2007; 46:595-600. (Pubitemid 47598980)
80. Wolkewitz M, Frank U, Philips G, et al. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother 2011; 66: 381-386.
81. Robins JM, Mark SD, Newey WK. Estimating exposure effects by modeling the expectation of exposure conditional on confounders. Biometrics 1992; 48:479-495.
82. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11:561-570. (Pubitemid 30660035)
83. Robins JM, Hernan MA, Rotnitzky A. Effect modification by time-varying covariates. Am J Epidemiol 2007; 166:994-1002; discussion 1003-1004.
84. Katzan IL, Cebul RD, Husak SH, et al. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003; 60:620-625. (Pubitemid 36246079)
85. BekaertM, Vansteelandt S, Mertens K. Adjusting for time-varying confounding in the subdistribution analysis of a competing risk. Lifetime Data Anal 2010; 16:45-70.
86. Vansteelandt S, Mertens K, Suetens C, Goetghebeur E. Marginal structural models for partial exposure regimes. Biostatistics 2009; 10:46-59. (Pubitemid 352847905)
87. Bekaert M, Timsit JF, Decruyenaere J, et al. Excess risk of death from ventilator associated pneumonia: a reappraisal using longitudinal causal analysis. Intensive Care Med 2009; 35 (Suppl):16-16.
88. Valentin A, Capuzzo M, Guidet B, et al. Patient safety in intensive care: results from the multinational Sentinel Events Evaluation (SEE) study. Intensive Care Med 2006; 32:1591-1598. (Pubitemid 44484350)